Piper Sandler on Kestra Medical Technologies (KMTS): 'A Name to Own Right Here'
Tweet Send to a Friend
Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $30.00 price target on Kestra Medical Technologies (NASDAQ: KMTS).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
